Cost-effectiveness analysis of chemotherapy for advanced gastric cancer in China. - Wikidata - awgldk - TriplyDB

Cost-effectiveness analysis of chemotherapy for advanced gastric cancer in China.

Cost-effectiveness analysis of chemotherapy for advanced gastric cancer in China.

http://www.wikidata.org/entity/Q43096314

about

Metastasis, risk factors and prognostic significance of splenic hilar lymph nodes in gastric adenocarcinoma.FOXM1 mediates resistance to docetaxel in gastric cancer via up-regulating Stathmin.Combined use of lysyl oxidase, carcino-embryonic antigen, and carbohydrate antigens improves the sensitivity of biomarkers in predicting lymph node metastasis and peritoneal metastasis in gastric cancer.Prognostic value of cancer stem cell marker CD133 expression in gastric cancer: a systematic review Docetaxel, cisplatin and fluorouracil (DCF) regimen compared with non-taxane-containing palliative chemotherapy for gastric carcinoma: a systematic review and meta-analysis Risk factors and prognostic significance of retropancreatic lymph nodes in gastric adenocarcinoma.A genetic polymorphism in TOX3 is associated with survival of gastric cancer in a Chinese population.c-Jun N-terminal kinase is required for thermotherapy-induced apoptosis in human gastric cancer cells.Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxel Associations between serum CA724 and HER2 overexpression among stage II-III resectable gastric cancer patients: an observational study.ERCC2 Lys751Gln and Asp312Asn polymorphisms and gastric cancer risk: a meta-analysis.Cost-effectiveness and safety of ramucirumab plus paclitaxel chemotherapy in the treatment of advanced and recurrent gastric cancer.The Cost Effectiveness of Docetaxel and Active Symptom Control versus Active Symptom Control Alone for Refractory Oesophagogastric Adenocarcinoma: Economic Analysis of the COUGAR-02 Trial.Astrocyte-elevated gene-1 overexpression is associated with poor prognosis in gastric cancer.Comparisons of short-term and survival outcomes of laparoscopy-assisted versus open total gastrectomy for gastric cancer patients.Digestive tract reconstruction pattern as a determining factor in postgastrectomy quality of life.Individualized proximal margin for early gastric cancer patients.Neoadjuvant plus adjuvant chemotherapy benefits overall survival of locally advanced gastric cancer.Combination of cecropinXJ and LY294002 induces synergistic cytotoxicity, and apoptosis in human gastric cancer cells via inhibition of the PI3K/Akt signaling pathway.Efficacy and cost-effectiveness of second-line chemotherapy in elderly patients with advanced gastric cancer.Cost-utility analysis of the newly recommended adjuvant chemotherapy for resectable gastric cancer patients in the 2011 Chinese National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Gastric Cancer.

P2860

Q33734862-1F544755-C1A6-4C06-83E1-18ADD3BB5851 Q33991617-CA37E8B1-2F6A-421E-8BD8-F8798DF92B38 Q34422525-EDBA1CE1-C879-446D-B5A3-D8A2862240BB Q34637735-A028E1B5-1307-48C5-A8A0-2B595CBF018A Q34672942-8266E6CE-E1FC-4238-B453-583550071E43 Q34997336-9CA2DC89-7986-4F96-91EF-7781DACEE7C2 Q34998461-87CA2D50-DD82-4BE4-BDF8-E1BB9A32E4E3 Q36529248-E1EA4DB2-2605-4B27-AD64-AFE41C335EE6 Q37153952-82400E64-5043-4DA3-9C42-E9E85B0DE222 Q37269090-4AEF6EDC-7541-4F70-9822-41B6E0DACF15 Q38426769-821699CF-376B-420E-B876-6300725B213F Q38823650-37FBE51C-C4DB-477C-835A-4AE6156412A2 Q38967142-F4757EC5-BFFF-46F4-BC92-54A30DC5154C Q39725792-7C0C56C1-5217-4D7C-A303-0AE516B2DE8B Q41592720-264A2E41-B32A-4E99-B792-F71AC6DE4633 Q42750591-778FD1DB-4B7A-4CA5-97D6-19EBC04E5E65 Q42754774-C749ED9F-E518-443E-8973-1FBE8FB63DF9 Q42971706-FE770655-E233-4154-A31F-8DAE7A75FAB8 Q49986452-22AC0EA8-547F-4322-90F8-D15B4CA42B21 Q50666978-CB5F203B-13C0-4BFE-9C1E-33771955011A Q51215133-4767F0A2-4E85-4244-B6A7-EC10C55B8AA1

P2860

Cost-effectiveness analysis of chemotherapy for advanced gastric cancer in China.

http://www.wikidata.org/entity/Q43096314

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Cost-effectiveness analysis of chemotherapy for advanced gastric cancer in China.

@en

Cost-effectiveness analysis of chemotherapy for advanced gastric cancer in China.

@nl

type

label

Cost-effectiveness analysis of chemotherapy for advanced gastric cancer in China.

@en

Cost-effectiveness analysis of chemotherapy for advanced gastric cancer in China.

@nl

prefLabel

Cost-effectiveness analysis of chemotherapy for advanced gastric cancer in China.

@en

Cost-effectiveness analysis of chemotherapy for advanced gastric cancer in China.

@nl

P1433

Q43096314-DA6205B3-AE69-45DC-940A-D7143CC3599C

P1476

Q43096314-2AFE55EF-BF6B-4709-B7C9-BD5E26DD2292

P2093

Q43096314-03CCDC99-23FF-4A57-8C54-FC63742D4BA9

Q43096314-2B43D796-3DBD-4070-A95A-74AFF75437AB

Q43096314-49801DD5-DD5C-4F79-9DF0-2745A58CDF78

Q43096314-4AA51517-BC70-4697-B58D-4476ED56487C

Q43096314-8C650A1A-BABD-47CD-91D7-C01F584842F7

Q43096314-F120AF41-3FB0-4640-ACEE-CC65B88BB751

Q43096314-F8A31EE3-C924-4F24-A19E-823AFC63CD28

Q43096314-FFC92D2F-FB30-43DB-B8B6-4EADDD142807

P2860

Q43096314-0ECD7C5E-97C5-43FF-8664-9669CFA8CA75

Q43096314-2C616ED9-C051-425D-A0A0-C2CDEE300C01

Q43096314-3799C090-DC3A-4614-AE5E-D4FB5651F9DB

Q43096314-40E87F5E-8F3B-4B3A-970E-69A9762270C8

Q43096314-725DEB01-06E4-433A-B3FE-88E66B17FA74

Q43096314-C230364A-C0F6-43E2-91DE-FCF04E557BF5

Q43096314-DA5118F6-5FB6-451D-8384-6904089C6C0E

Q43096314-E39870D7-D689-4CA7-B564-C9C64C0970EA

P304

Q43096314-6FDE7BBB-7A41-41AE-896E-046088DD9A94

P31

Q43096314-09005184-E96A-4D40-87AF-1D0166E4D96E

P356

Q43096314-21A7ED50-8A0C-4ED2-A02A-B8FD0A9AD9A8

P407

Q43096314-9504C61C-5424-4648-9933-8FD2808ADE5C

P433

Q43096314-6C4E0F07-33A2-4869-A419-CC72D2149D80

P478

Q43096314-E090D7C6-3EE4-4409-9978-E87516E88649

P577

Q43096314-67196A61-29C5-4267-9059-41CC52402044

P698

Q43096314-2160BDAE-939C-4B63-B79A-147124B51D4A

P921

Q43096314-6ACF78BD-2772-47B2-B6FA-4907C62F30BF

P932

Q43096314-CEE6B492-9446-44F0-9719-4C9A376861E4

P356

P1433

World Journal of Gastroenterology

P1476

Cost-effectiveness analysis of chemotherapy for advanced gastric cancer in China.

@en

P2093

Bo Zhang

http://www.w3.org/2001/XMLSchema#string

Hong-Feng Gou

http://www.w3.org/2001/XMLSchema#string

Jia-Ping Chen

http://www.w3.org/2001/XMLSchema#string

Jian-Kun Hu

http://www.w3.org/2001/XMLSchema#string

Kun Jiang

http://www.w3.org/2001/XMLSchema#string

Kun Yang

http://www.w3.org/2001/XMLSchema#string

Xin-Zu Chen

http://www.w3.org/2001/XMLSchema#string

Zhi-Xin Chen

http://www.w3.org/2001/XMLSchema#string

P2860

The effectiveness of intravenous 5-fluorouracil-containing chemotherapy after curative resection for gastric carcinoma: A systematic review of published randomized controlled trials.

A pilot phase II study of chemotherapy with oxaliplatin, folinic acid, 5-fluorouracil and irinotecan in metastatic gastric cancer.

Docetaxel-based chemotherapy in the treatment of gastric cancer.

Review of capecitabine as oral treatment of gastric, gastroesophageal, and esophageal cancers.

Chemotherapy of advanced gastric cancer.

Detection of micrometastasis of gastric carcinoma in peripheral blood circulation

Combination chemotherapy with 5-fluorouracil, cisplatin and paclitaxel for pretreated patients with advanced gastric cancer.

A phase II study of irinotecan with bi-weekly, low-dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFIRI) as salvage therapy for patients with advanced or metastatic gastric cancer.

P304

2715-2722

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.14.2715

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18461656

http://www.w3.org/2001/XMLSchema#string

P921

P932

2709040

http://www.w3.org/2001/XMLSchema#string